{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:55:37Z","timestamp":1791406537293,"version":"4.3.3"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ejim.2026.107117","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:14:16Z","timestamp":1786493656000},"page":"107117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Personalizing cardiovascular prevention in chronic kidney disease: an operational framework for risk-treatment mapping"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6616-1996","authenticated-orcid":false,"given":"Carmine","family":"Zoccali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba P","family":"Kovesdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Mallamaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navdeep","family":"Tangri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vianda","family":"Stel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Stenvinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kitty","family":"Jager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2026.107117_bib0001","article-title":"Chronic cardiovascular-kidney disorder: a new conceptual framework","author":"Zoccali","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ejim.2026.107117_bib0002","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2026.107117_bib0003","unstructured":"Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. The Lancet 20103; 75: 2073\u20132081. https:\/\/www.thelancet.com\/action\/showFullText?pii=S0140673610606745."},{"key":"10.1016\/j.ejim.2026.107117_bib0004","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.kint.2025.10.004","article-title":"Perkovic V: From progression to remission: a new paradigm for success in chronic kidney disease","volume":"109","author":"Tangri","year":"2026","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2026.107117_bib0005","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/jama.2011.451","article-title":"A predictive model for progression of chronic kidney disease to kidney failure","volume":"305","author":"Tangri","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2026.107117_bib0006","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Development and Validation of the American Heart Association\u2019s PREVENT Equations","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2026.107117_bib0007","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","article-title":"SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe","volume":"42","author":"collaboration S working group and EC risk","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2026.107117_bib0008","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/eurjpc\/zwac176","article-title":"Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP","volume":"30","author":"Matsushita","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ejim.2026.107117_bib0009","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41581-025-00931-8","article-title":"Grams ME: Risk-directed management of chronic kidney disease","volume":"21","author":"Blum","year":"2025","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ejim.2026.107117_bib0010","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.2337\/dc22-0698","article-title":"Development and Validation of Prediction Models of Adverse Kidney Outcomes in the Population With and Without Diabetes","volume":"45","author":"Grams","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejim.2026.107117_bib0011","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1111\/dom.15678","article-title":"Machine learning for prediction of chronic kidney disease progression: Validation of the Klinrisk model in the CANVAS Program and CREDENCE trial","volume":"26","author":"Tangri","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ejim.2026.107117_bib0012","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.kint.2018.01.009","article-title":"Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate","volume":"93","author":"Grams","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2026.107117_bib0013","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1681\/ASN.0000000000000377","article-title":"Individualized Risk of CKD Progression among US Adults","volume":"35","author":"Tio","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2026.107117_bib0014","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41581-018-0016-4","article-title":"Rethinking progression of CKD as a process of punctuated equilibrium","volume":"14","author":"Johnson","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ejim.2026.107117_bib0015","article-title":"Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study","volume":"357","author":"Hippisley-Cox","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2026.107117_bib0016","doi-asserted-by":"crossref","first-page":"20","DOI":"10.7326\/M17-3011","article-title":"Clinical Implications of Revised Pooled Cohort Equations for Estimating Atherosclerotic Cardiovascular Disease Risk","volume":"169","author":"Yadlowsky","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2026.107117_bib0017","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","article-title":"SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe","volume":"42","author":"group","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2026.107117_bib0018","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1093\/eurheartj\/ehad260","article-title":"SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe","volume":"44","author":"Pennells","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2026.107117_bib0019","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1016\/j.ekir.2021.09.006","article-title":"The Effect of Age on Performance of the Kidney Failure Risk Equation in Advanced CKD","volume":"6","author":"Hundemer","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ejim.2026.107117_bib0020","first-page":"1219","volume":"4","author":"Akbilgic","year":"2019","journal-title":"Machine Learning to Identify Dialysis Patients at High Death Risk. Kidney Int Rep"},{"key":"10.1016\/j.ejim.2026.107117_bib0021","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"105","author":"Stevens","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2026.107117_bib0022","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1080\/00325481.2024.2418795","article-title":"SGLT2 inhibitors across the spectrum of chronic kidney disease: a narrative review","volume":"136","author":"Sloan","year":"2024","journal-title":"Postgrad Med"},{"key":"10.1016\/j.ejim.2026.107117_bib0023","author":"Statins in Chronic","year":"2026","journal-title":"Kidney Disease and Dialysis: Clinical Trials, Mechanisms, Dosing, and Treatment Recommendations | National Lipid Association Online n.d"},{"key":"10.1016\/j.ejim.2026.107117_bib0024","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.3390\/jcm14196758","article-title":"GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies","volume":"14","author":"Yang","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.ejim.2026.107117_bib0025","doi-asserted-by":"crossref","first-page":"6285","DOI":"10.3390\/jcm12196285","article-title":"Nonsteroidal Mineralocorticoid Receptor Antagonist (Finerenone) in Cardiorenal Disease","volume":"12","author":"Shah","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.ejim.2026.107117_bib0026","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2147\/VHRM.S275739","article-title":"PCSK9 Inhibitors in the Management of Cardiovascular Risk: A Practical Guidance","volume":"18","author":"Jia","year":"2022","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.ejim.2026.107117_bib0027","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1186\/s12882-025-04347-1","article-title":"Efficacy and safety of PCSK9 inhibitors in patients with chronic kidney disease","volume":"26","author":"Tang","year":"2025","journal-title":"BMC Nephrology"},{"issue":"5","key":"10.1016\/j.ejim.2026.107117_bib0028","doi-asserted-by":"crossref","first-page":"841","DOI":"10.34067\/KID.0000000000000447","article-title":"Polypharmacy in Patients with CKD: A Systematic Review and Meta-Analysis","volume":"360","author":"Oosting","year":"2024","journal-title":"Kidney"},{"key":"10.1016\/j.ejim.2026.107117_bib0029","doi-asserted-by":"crossref","DOI":"10.1111\/fcp.70037","article-title":"Drug Exposure in Chronic Kidney Disease: It Is Not Just About the Glomerular Filtration Rate","volume":"39","author":"Liabeuf","year":"2025","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.ejim.2026.107117_bib0030","article-title":"Gut microbiota composition is associated with polypharmacy in elderly hospitalized patients","volume":"7","author":"Ticinesi","year":"2017"},{"key":"10.1016\/j.ejim.2026.107117_bib0031","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.sapharm.2025.05.005","article-title":"Deprescribing tools and guidelines in chronic kidney disease: A scoping review","volume":"21","author":"Zidan","year":"2025","journal-title":"Research in Social and Administrative Pharmacy"},{"issue":"2","key":"10.1016\/j.ejim.2026.107117_bib0032","first-page":"1501","article-title":"Less is More: Deprescribing Medications in Older Adults with Kidney Disease: A Review","volume":"360","author":"Mohottige","year":"2021","journal-title":"Kidney"},{"key":"10.1016\/j.ejim.2026.107117_bib0033","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1056\/NEJMoa2513032","article-title":"Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis","volume":"394","author":"Lok","year":"2026","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.ejim.2026.107117_bib0034","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae008","article-title":"Kidney Failure Risk Equation in vascular access planning: a population-based study supporting value in decision making","volume":"17","author":"Atiquzzaman","year":"2024","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ejim.2026.107117_bib0035","article-title":"Prediction of estimated glomerular filtration rate slope and kidney prognosis of patients with chronic kidney disease","author":"Nagasu","year":"2026","journal-title":"Scientific Reports"},{"key":"10.1016\/j.ejim.2026.107117_bib0036","article-title":"Strategies for Embedding Prediction Models in Clinical Decision-Making Workflows","volume":"18","author":"Amusa","year":"2026","journal-title":"Cureus"},{"key":"10.1016\/j.ejim.2026.107117_bib0037","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/informatics7030025","article-title":"Clinical Implementation of Predictive Models Embedded within Electronic Health Record Systems: A Systematic Review","volume":"7","author":"Lee","year":"2020","journal-title":"Informatics (MDPI)"},{"key":"10.1016\/j.ejim.2026.107117_bib0038","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.0427","article-title":"Representation of Patients With Chronic Kidney Disease in Clinical Trials of Cardiovascular Disease Medications: A Systematic Review","volume":"7","author":"Colombijn","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejim.2026.107117_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pdig.0000278","article-title":"Bias in artificial intelligence algorithms and recommendations for mitigation","volume":"2","author":"Nazer","year":"2023","journal-title":"PLOS Digital Health"},{"key":"10.1016\/j.ejim.2026.107117_bib0040","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1681\/ASN.2015111264","article-title":"Pragmatic Clinical Trials in CKD: Opportunities and Challenges","volume":"27","author":"De Boer","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2026.107117_bib0041","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1186\/s12913-025-13346-9","article-title":"Use of implementation science frameworks to identify core components and sustainability characteristics of a quality improvement learning collaborative","volume":"25","author":"McNamara","year":"2025","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.ejim.2026.107117_bib0042","doi-asserted-by":"crossref","DOI":"10.2215\/CJN.0000001054","article-title":"Chronic Inflammation as an Overlooked Link between Cardiovascular and Kidney Diseases: Focus on Interleukin 6 and C-Reactive Protein","author":"Pergola","year":"2026","journal-title":"Clinical Journal of the American Society of Nephrology"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362052600422X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362052600422X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:14:22Z","timestamp":1786493662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095362052600422X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":42,"alternative-id":["S095362052600422X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2026.107117","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Personalizing cardiovascular prevention in chronic kidney disease: an operational framework for risk-treatment mapping","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2026.107117","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}],"article-number":"107117"}}